And in some cases regular treatments with Lupron (leuprolide) or Zoladex (goserelin) is frequently not accessible and/or much too expensive. Just lately developed ADT treatments for instance abiraterone and enzalutamide are fully out of get to economically for some African people and often not accessible in the least in low- and lower-middle-revenu